Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 104 entries
View as:

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05355558 Org: User:
Start: 05/14/19 End: 12/31/22 Due: 12/31/23

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05581979 Org: User:
Start: 01/26/22 End: 06/30/24 Due: 06/30/25

Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)

Phase: N/A Priority: Normal
NCT ID: NCT06044441 Org: User:
Start: 12/26/23 End: 06/30/26 Due: 06/30/27

Using QPOP to Predict Treatment for Sarcomas and Melanomas

Phase: N/A Priority: Normal
NCT ID: NCT04986748 Org: User:
Start: 09/08/20 End: 12/31/28 Due: 12/31/29

LiverMultiScan Analysis of MRI Scans in HCC

Phase: N/A Priority: Normal
NCT ID: NCT04451603 Org: User:
Start: 10/19/18 End: 12/31/23 Due: 12/31/24

Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital

Phase: N/A Priority: Normal
NCT ID: NCT03330509 Org: User:
Start: 12/01/17 End: 12/30/21 Due: 12/30/22

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04087473 Org: User:
Start: 08/23/19 End: 12/31/25 Due: 12/31/26

Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02808091 Org: User:
Start: 03/31/11 End: 03/31/14 Due: 03/31/15

A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06418412 Org: User:
Start: 03/15/24 End: 12/31/26 Due: 12/31/27

Phase 2 Study of Dacomitinib in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04027647 Org: User:
Start: 09/11/19 End: 03/31/26 Due: 03/31/27

Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

Phase: N/A Priority: Normal
NCT ID: NCT04452084 Org: User:
Start: 06/15/20 End: 07/01/24 Due: 07/01/25

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02736305 Org: User:
Start: 02/03/16 End: 11/18/19 Due: 11/18/20

A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05773092 Org: User:
Start: 08/01/23 End: 03/31/28 Due: 03/31/29

Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03422432 Org: User:
Start: 09/28/17 End: 12/13/24 Due: 12/13/25

ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore

Phase: N/A Priority: Normal
NCT ID: NCT05211882 Org: User:
Start: 02/14/22 End: 03/25/25 Due: 03/25/26

Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT01716689 Org: User:
Start: 06/30/12 End: 10/31/16 Due: 10/31/17

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

Phase: N/A Priority: Normal
NCT ID: NCT06977360 Org: User:
Start: 07/31/25 End: 12/31/25 Due: 12/31/26

Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02313298 Org: User:
Start: 06/30/13 End: 12/31/21 Due: 12/31/22

Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03033446 Org: User:
Start: 12/20/16 End: 12/31/25 Due: 12/31/26

Longitudinal Immune-phenotyping of HCC Following MK-3475

Phase: N/A Priority: Normal
NCT ID: NCT04224480 Org: User:
Start: 12/10/19 End: 12/31/25 Due: 12/31/26

Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00467194 Org: User:
Start: 12/31/06 End: - Due: -

Telegenetics or In-Person Genetic Counselling

Phase: N/A Priority: Normal
NCT ID: NCT04738708 Org: User:
Start: 02/01/21 End: 10/16/25 Due: 10/16/26

Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06587295 Org: User:
Start: 01/15/25 End: 12/31/26 Due: 12/31/27

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04303403 Org: User:
Start: 07/31/18 End: 03/31/24 Due: 03/31/25

Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO

Phase: N/A Priority: Normal
NCT ID: NCT03515174 Org: User:
Start: 04/16/18 End: 02/28/23 Due: 02/28/24